An open label study in healthy volunteers to investigate the effect of ketoconazole on the pharmacokinetics of GSK189075.
Latest Information Update: 31 Jul 2023
At a glance
- Drugs Remogliflozin etabonate (Primary) ; Ketoconazole
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 13 Aug 2007 New trial record.